Literature DB >> 6823333

Abnormal mRNA for argininosuccinate synthetase in citrullinaemia.

T S Su, A L Beaudet, W E O'Brien.   

Abstract

Citrullinaemia is a human inborn error of metabolism resulting from the deficiency of argininosuccinate synthetase. In a previous study of cultured skin fibroblasts from citrullinaemia patients, we showed that the presumed defects in DNA were not detectable by Southern blotting analysis, and that only 2 of 11 cell lines contained detectable enzyme antigen. All citrullinaemia cell lines contained hybridizable mRNA but slight size heterogeneity was noted. Here we report the extension of the analysis of the RNA using S1 nuclease mapping techniques. Among six cell lines examined, five showed an abnormality of mRNA detectable by S1 nuclease analysis. The data indicate that a minimum of three out of five non-consanguineous patients represent compound heterozygotes. The S1 nuclease detectable defects may represent deletions or rearrangements in the genomic DNA, or more probably represent examples of abnormal RNA splicing. The approach used here is useful for molecular analysis of genetic defects, for prenatal diagnosis, and for study of genetic variation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6823333     DOI: 10.1038/301533a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

1.  Molecular definition of bovine argininosuccinate synthetase deficiency.

Authors:  J A Dennis; P J Healy; A L Beaudet; W E O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Allan Award Introduction: Arthur L. Beaudet.

Authors:  James R Lupski
Journal:  Am J Hum Genet       Date:  2008-05       Impact factor: 11.025

3.  Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells.

Authors:  P J Mitchell; G Urlaub; L Chasin
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Molecular structure of the human argininosuccinate synthetase gene: occurrence of alternative mRNA splicing.

Authors:  S O Freytag; A L Beaudet; H G Bock; W E O'Brien
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

5.  Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.

Authors:  G S Adrian; D A Wiginton; J J Hutton
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

6.  Sequence for human argininosuccinate synthetase cDNA.

Authors:  H G Bock; T S Su; W E O'Brien; A L Beaudet
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

7.  A carbamylphosphate synthetase deficiency with no detectable immunoreactive enzyme and no translatable mRNA.

Authors:  L Graf; P McIntyre; N Hoogenraad; G Brown; E A Haan
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Level of translatable messenger RNA coding for argininosuccinate synthetase in the liver of the patients with quantitative-type citrullinemia.

Authors:  M Sase; K Kobayashi; Y Imamura; T Saheki; K Nakano; S Miura; M Mori
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia.

Authors:  K Kobayashi; H Kakinoki; T Fukushige; N Shaheen; H Terazono; T Saheki
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

10.  Homocystinuria: biogenesis of cystathionine beta-synthase subunits in cultured fibroblasts and in an in vitro translation system programmed with fibroblast messenger RNA.

Authors:  F Skovby; J P Kraus; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.